# 1. Target: GSR
6 regulons containing the target(s), GSR are overactive in this patient.
None
# 1. Target: RRM2
12 regulons containing the target(s), RRM2 are overactive in this patient.
None
14 regulons containing the target(s), FNTA,FNTB are overactive in this patient.
13 regulons containing the target(s), WEE1 are overactive in this patient.
None
21 regulons containing the target(s), JAK1,JAK2 are overactive in this patient.
None
No additional evidence was found
# 1. Target: APP
41 regulons containing the target(s), APP are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
16 regulons containing the target(s), TNFRSF1A are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
8 regulons containing the target(s), PLA2G2A,PLA2G5 are overactive in this patient.
HALLMARK_TNFA_SIGNALING_VIA_NFKB HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
4 regulons containing the target(s), JAK1 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
10 regulons containing the target(s), TNC are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
15 regulons containing the target(s), CA2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
51 regulons containing the target(s), UGCG are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), ABL1 are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
11 regulons containing the target(s), OXTR are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), BSG are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), NDUFA13 are overactive in this patient.
HALLMARK_OXIDATIVE_PHOSPHORYLATION HALLMARK_DNA_REPAIR HALLMARK_MYC_TARGETS_V1
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), TSG101 are overactive in this patient.
HALLMARK_OXIDATIVE_PHOSPHORYLATION HALLMARK_DNA_REPAIR HALLMARK_MYC_TARGETS_V1
No glioblastoma clinical trials were found for these drugs.
17 regulons containing the target(s), ABAT are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), NQO1 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), PLA2G2A are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
1 regulons containing the target(s), ELN are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
1 regulons containing the target(s), TRPV4 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
14 regulons containing the target(s), FNTA,FNTB are overactive in this patient.
28 regulons containing the target(s), HSPA8 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
12 regulons containing the target(s), RRM2 are overactive in this patient.
None
No glioblastoma clinical trials were found for these drugs.
18 regulons containing the target(s), MAPK1,MAPK3 are overactive in this patient.
None
No additional evidence was found
23 regulons containing the target(s), ANGPT2 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
21 regulons containing the target(s), JAK1,JAK2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
13 regulons containing the target(s), SLC6A9 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
6 regulons containing the target(s), GSR are overactive in this patient.
None
No glioblastoma clinical trials were found for these drugs.
41 regulons containing the target(s), HRH1 are overactive in this patient.
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_KRAS_SIGNALING_UP
No additional evidence was found
17 regulons containing the target(s), JAK2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
63 regulons containing the target(s), ATP1A1 are overactive in this patient.
HALLMARK_TNFA_SIGNALING_VIA_NFKB HALLMARK_UV_RESPONSE_DN HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), SOD1 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), ACVR2B are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
15 regulons containing the target(s), CA2,CA4 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
23 regulons containing the target(s), ANGPT1,ANGPT2 are overactive in this patient.
No additional evidence was found
9 regulons containing the target(s), EEF2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
41 regulons containing the target(s), HRH1,SLC6A2 are overactive in this patient.
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_KRAS_SIGNALING_UP
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
28 regulons containing the target(s), ANGPT2,VEGFA are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
***Warning message: Missing column names filled in: ‘X15’ [15], ‘X16’ [16], ‘X17’ [17], ‘X18’ [18], ‘X19’ [19], ‘X20’ [20], ‘X21’ [21], ‘X22’ [22], ‘X23’ [23], ‘X24’ [24], ‘X25’ [25], ‘X26’ [26], ‘X27’ [27], ‘X28’ [28], ‘X29’ [29], ‘X30’ [30], ‘X31’ [31], ‘X32’ [32], ‘X33’ [33], ‘X34’ [34], ‘X35’ [35], ‘X36’ [36], ‘X37’ [37], ‘X38’ [38], ‘X39’ [39], ‘X40’ [40], ‘X41’ [41], ‘X42’ [42], ‘X43’ [43], ‘X44’ [44], ‘X45’ [45], ‘X46’ [46], ‘X47’ [47], ‘X48’ [48], ‘X49’ [49], ‘X50’ [50], ‘X51’ [51], ‘X52’ [52], ‘X53’ [53], ‘X54’ [54], ‘X55’ [55], ‘X56’ [56], ‘X57’ [57], ‘X58’ [58], ‘X59’ [59], ‘X60’ [60], ‘X61’ [61], ‘X62’ [62], ‘X63’ [63], ‘X64’ [64], ‘X65’ [65], ‘X66’ [66], ‘X67’ [67], ‘X68’ [68], ‘X69’ [69], ‘X70’ [70], ‘X71’ [71], ‘X72’ [72], ‘X73’ [73], ‘X74’ [74], ‘X75’ [75], ‘X76’ [76], ‘X77’ [77], ‘X78’ [78], ‘X79’ [79], ‘X80’ [80], ‘X81’ [81], ‘X82’ [82], ‘X83’ [83], ‘X84’ [84], ‘X85’ [85], ‘X86’ [86], ‘X87’ [87], ‘X88’ [88], ‘X89’ [89], ‘X90’ [90], ‘X91’ [91], ‘X92’ [92], ‘X93’ [93], ‘X94’ [94], ‘X95’ [9 [… truncated]